SCHEMBL29978591

SCHEMBL29978591

CS(=O)(=O)c1ccc(S(=O)(=O)NCc2ccccc2N2CCCCC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.56
PKM P14618 1/20 0.47
MCOLN3 Q8TDD5 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
FABP3 P05413 1/20 0.46
FABP4 P15090 1/20 0.46
POLB P06746 3/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
KMO O15229 2/20 0.45
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
GAA P10253 1/20 0.43
LIPG Q9Y5X9 1/20 0.42
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043704 1.00 PTGS2 (0.56) PTGS2PKMMCOLN3L3MBTL1MEN1
SCHEMBL23057125 0.86 KMT2A (0.49) PKMMCOLN3L3MBTL1MEN1KMT2A
SCHEMBL23355005 0.85 KMT2A (0.50) L3MBTL1MEN1KMT2APOLBALDH1A1
SCHEMBL31017284 0.81 MAPT (0.47) PKMMCOLN3L3MBTL1MEN1KMT2A
SCHEMBL26919920 0.81 MAPT (0.47) PKMMCOLN3L3MBTL1MEN1KMT2A
SCHEMBL14355762 0.79 HTR6 (0.49) MEN1KMT2APOLBTP53MAPT
SCHEMBL23043616 0.77 MCOLN3 (0.76) PTGS2PKMMCOLN3L3MBTL1MEN1
SCHEMBL29979148 0.77 MCOLN3 (0.76) PTGS2PKMMCOLN3L3MBTL1MEN1
SCHEMBL5165487 0.77 GAA (0.51) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL14355983 0.76 HTR6 (0.55) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 PTGS2 4379/4885PKM 3754/4885MCOLN3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.